bullish
WuXi AppTec (603259.CH/2359.HK) - The Smart Business Model
218 Views21 Sep 2021 08:59
The article mainly analyzed WuXi AppTec in terms of its 2021/1H performance,the business model(traditional CRO/CDMO services, venture and fund investments),the concerns and the outlook of the Company.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- Pre-IPO Sirnaomics Ltd. - Cautious Optimism Is Still Recommended29 Sep 2021
- Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum28 Sep 2021
- China Healthcare Weekly (Sep.24) - VBP on Neuro-Intervention, Payment System Changes, AI in Drug R&D26 Sep 2021
- WuXi AppTec (603259.CH/2359.HK) - The Smart Business Model21 Sep 2021
- Pre-IPO Novotech Holdings - The Future Would Not Be Easy06 Jul 2021
- WuXi AppTec (2359.HK) - The Certainties and the Uncertainties03 Jun 2021
- WuXi Biologics (2269 HK) - The Strength and the Potential Risk01 Apr 2021
x